NIH-funded research R01 grant

Context-specific pathway dependencies for nuclear envelope proteins in brain cancer

Funded at Dana-Farber Cancer Inst · NIH-11366260 · Data updated 2026-11-12

This grant explores how nuclear envelope proteins influence brain cancer behavior using cancer cell models to map signaling and functional networks.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDana-Farber Cancer Inst
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2026
Project endJune 30, 2031
Funding year2026
Award (this year)$718,275
NIH project number1R01CA303334-01A1
Project IDNIH-11366260 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to patient participation in this stage of the project; uses cancer cell lines and computational analyses.

Less likely to help

No direct patient involvement or benefits at this stage.

What this research studies

Researchers will study how nuclear envelope proteins act differently across brain cancer cell lines, using advanced analyses to separate distinct functions of these proteins. They will apply a framework called Webster to identify context-specific roles in cancer cells and highlight which cellular contexts are most relevant for particular protein functions. The project will leverage large-scale cancer cell line data to link nuclear envelope biology to disease-specific phenotypes in brain tumors. The work aims to clarify how mutations in nuclear envelope genes contribute to brain cancer complexity and potential therapeutic angles.

Why it matters

Potential benefit: If successful, it could clarify disease mechanisms in brain cancer and guide future targeted therapies.

How similar studies have gone: Previous research using large cancer cell line datasets has begun to map functional networks, with growing evidence that context matters for gene effects.

Where this research is happening

  • Dana-Farber Cancer Inst
    Boston, United States
    Active

Researchers

  • Principal investigator: Hahn, William C. — Dana-Farber Cancer Inst
  • Study coordinator: Hahn, William C.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.